JABCX
Price
$50.05
Change
+$0.16 (+0.32%)
Updated
Oct 17 closing price
Net Assets
28.02B
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

JABCX vs RLBCX

Header iconJABCX vs RLBCX Comparison
Open Charts JABCX vs RLBCXBanner chart's image
Janus Henderson Balanced C
Price$50.05
Change+$0.16 (+0.32%)
VolumeN/A
Net Assets28.02B
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
JABCX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
JABCX vs. RLBCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JABCX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. JABCX (28B). RLBCX pays higher dividends than JABCX: RLBCX (1.49) vs JABCX (0.91). JABCX was incepted earlier than RLBCX: JABCX (16 years) vs RLBCX (23 years). JABCX (1.63) is less costly to investors than RLBCX (0.89). JABCX is a more actively managed with annual turnover of: 76.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than JABCX: RLBCX (250) vs JABCX (2500). RLBCX annual gain was more profitable for investors over the last year : 8.34 vs. JABCX (6.46). RLBCX return over 5 years is better than : 40.24 vs. JABCX (32.61).
JABCXRLBCXJABCX / RLBCX
Total Expense Ratio1.630.89183%
Annual Report Gross Expense Ratio1.630.89183%
Fund Existence16 years23 years-
Gain YTD12.15314.36485%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets28B265B11%
Annual Yield % from dividends0.911.4961%
Returns for 1 year6.468.3477%
Returns for 3 years43.3449.2688%
Returns for 5 years32.6140.2481%
Returns for 10 years83.1072.18115%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBM3.520.07
+2.03%
Psyence Biomedical Ltd
CVGW23.810.14
+0.59%
Calavo Growers
SWK67.85-0.06
-0.09%
Stanley Black & Decker
IQ2.03-0.03
-1.46%
iQIYI
PMVP1.40-0.04
-2.78%
PMV Pharmaceuticals